Skin cancer screening programs have led to diagnoses of melanoma that would have otherwise been missed, but the overall public health benefit of such programs remains unclear.
Recent research implicates patients’ immune cells appear to stimulate radiation abscopal effects, raising the possibility that combining radiotherapy and immunotherapy could yield previously-untapped treatment synergies to improve tumor control.
A review of current options and ongoing trials for managing ARIE, a common esophageal adverse effect caused by radiotherapy to the thoracic region for lung, breast, or head and neck cancers, or lymphoma.
Research into the potential of radiation therapy in the management of mesothelioma may improve the prognosis, and possibly extend progression-free survival, for patients with this incurable cancer.
Advances in breast imaging such as DBT offer better, clearer images of breast tissue that can identify even low-grade DCIS tumors. But will more sensitive imaging lead to improved outcomes or increased overtreatment?
At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.
Cardio-oncology is an emerging interdisciplinary practice poised to address care patients who need concurrent cancer and cardiovascular disease therapies as well as the late effects of cancer and cancer treatments.
Seventy percent of Americans surveyed in this year’s National Cancer Opinion Survey were unaware that alcohol is a well-established and modifiable risk factor for cancer, the authors noted.
Combining radiotherapy and immunotherapy has shown early promise against some advanced cancers, but oncology nurses need to be wary of potential overlapping toxicity profiles from each of these treatment modalities.